Entero Healthcare Solutions Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 23, 2024, 10:04 am

Market Cap	6,060 Cr.
Current Price	1,393
High / Low	1,584/970
Stock P/E	84.8
Book Value	387
Dividend Yield	0.00 %
ROCE	6.71 %
ROE	4.98 %
Face Value	10.0
PEG Ratio	0.40

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Entero Healthcare Solutions Ltd

Competitors of

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Entero Healthcare Solutions Ltd	6,060 Cr.	1,393	1,584/970	84.8	387	0.00 %	6.71 %	4.98 %	10.0
Industry Average	6,060.00 Cr	1,393.00		84.80	387.00	0.00%	6.71%	4.98%	10.00

All Competitor Stocks of

Quarterly Result

Month	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	829	887	899	996	993	1,034	1,097
Expenses	810	867	873	968	964	1,005	1,067
Operating Profit	19	20	26	29	29	29	30
OPM %	2%	2%	3%	3%	3%	3%	3%
Other Income	2	1	1	2	2	9	13
Interest	13	13	14	18	16	17	10
Depreciation	5	7	6	6	6	7	7
Profit before tax	2	1	7	7	8	14	27
Tax %	-44%	490%	6%	23%	16%	-56%	25%
Net Profit	4	-4	6	5	7	21	21
EPS in Rs	8.05	-9.05	15.18	3.19	4.22	4.82	4.62

Last Updated: October 7, 2024, 8:07 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: September 23, 2024, 2:31 pm

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,780	2,522	3,300	3,922	4,120
Expenses	1,758	2,498	3,236	3,810	4,004
Operating Profit	22	24	64	112	116
OPM %	1%	1%	2%	3%	3%
Other Income	4	4	6	14	26
Interest	20	29	49	66	61
Depreciation	16	20	24	25	26
Profit before tax	-11	-20	-4	36	56
Tax %	42%	49%	201%	-12%
Net Profit	-15	-29	-11	40	54
EPS in Rs	-1,550.90	-77.71	-28.12	8.99	16.85
Dividend Payout %	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-93.33%	62.07%	463.64%
Change in YoY Net Profit Growth (%)	0.00%	155.40%	401.57%

Entero Healthcare Solutions Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 3 years from 2021-2022 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	30%
TTM:	23%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	66%
TTM:	552%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	5%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 4:32 pm

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	0.10	4	4	43	43
Reserves	-32	-62	-73	1,595	1,639
Borrowings	720	974	1,101	338	361
Other Liabilities	145	210	275	369	609
Total Liabilities	833	1,125	1,308	2,345	2,653
Fixed Assets	189	262	268	289	554
CWIP	2	1	0	0	0
Investments	0	0	0	0	3
Other Assets	643	863	1,040	2,056	2,096
Total Assets	833	1,125	1,308	2,345	2,653

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-69	-35	-45	-37
Cash from Investing Activity +	-31	-162	-49	-704
Cash from Financing Activity +	89	211	73	863
Net Cash Flow	-11	14	-21	122

Free Cash Flow

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-698.00	-950.00	63.00	-226.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	50	54	57	57
Inventory Days	54	49	41	43
Days Payable	22	22	25	24
Cash Conversion Cycle	82	81	73	77
Working Capital Days	84	79	72	71
ROCE %		1%	5%	7%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2024	Jun 2024	Sep 2024
Promoters	52.44%	52.44%	52.44%
FIIs	23.30%	23.32%	23.82%
DIIs	2.28%	2.06%	7.73%
Public	21.99%	22.18%	16.02%
No. of Shareholders	80,864	66,400	36,767

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	10.81	-3.10	-9.22	-5.29
Diluted EPS (Rs.)	10.81	-3.10	-9.22	-5.29
Cash EPS (Rs.)	14.90	31.94	-25.16	92.20
Book Value[Excl.RevalReserv]/Share (Rs.)	377.38	-160.39	-144.87	-3005.20
Book Value[Incl.RevalReserv]/Share (Rs.)	377.38	-160.39	-144.87	-3005.20
Revenue From Operations / Share (Rs.)	901.80	8025.80	6550.82	177973.70
PBDIT / Share (Rs.)	29.03	169.07	75.12	2547.60
PBIT / Share (Rs.)	23.28	110.13	23.81	920.00
PBT / Share (Rs.)	8.17	-8.97	-51.46	-1083.80
Net Profit / Share (Rs.)	9.15	-27.00	-76.46	-1535.40
NP After MI And SOA / Share (Rs.)	8.99	-28.11	-77.71	-1553.70
PBDIT Margin (%)	3.21	2.10	1.14	1.43
PBIT Margin (%)	2.58	1.37	0.36	0.51
PBT Margin (%)	0.90	-0.11	-0.78	-0.60
Net Profit Margin (%)	1.01	-0.33	-1.16	-0.86
NP After MI And SOA Margin (%)	0.99	-0.35	-1.18	-0.87
Return on Networth / Equity (%)	2.38	0.00	0.00	0.00
Return on Capital Employeed (%)	5.80	6.61	1.38	1.68
Return On Assets (%)	1.66	-0.88	-2.65	-1.86
Long Term Debt / Equity (X)	0.02	-0.45	-0.64	0.00
Total Debt / Equity (X)	0.16	-5.45	-4.92	-4.46
Asset Turnover Ratio (%)	2.15	2.71	2.57	0.00
Current Ratio (X)	3.34	1.64	1.84	2.19
Quick Ratio (X)	2.64	1.09	1.17	1.35
Interest Coverage Ratio (X)	1.92	1.42	0.99	1.27
Interest Coverage Ratio (Post Tax) (X)	1.61	0.77	-0.01	0.23
Enterprise Value (Cr.)	3669.42	0.00	0.00	0.00
EV / Net Operating Revenue (X)	0.93	0.00	0.00	0.00
EV / EBITDA (X)	29.06	0.00	0.00	0.00
MarketCap / Net Operating Revenue (X)	1.09	0.00	0.00	0.00
Price / BV (X)	2.62	0.00	0.00	0.00
Price / Net Operating Revenue (X)	1.09	0.00	0.00	0.00
EarningsYield	0.01	0.00	0.00	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Entero Healthcare Solutions Ltd as of December 23, 2024 is: 1,667.00

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 23, 2024, Entero Healthcare Solutions Ltd is Undervalued by 19.67% compared to the current share price 1,393.00

Intrinsic Value of Entero Healthcare Solutions Ltd as of December 23, 2024 is: 5,212.00

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 23, 2024, Entero Healthcare Solutions Ltd is Undervalued by 274.16% compared to the current share price 1,393.00

Last 5 Year EPS CAGR: 212.66%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has shown consistent growth in sales (2.60 cr) and profit (11.40 cr) over the years.	The stock has a low average ROCE of 3.25%, which may not be favorable. The stock has a high average Working Capital Days of 76.50, which may not be favorable. The stock has a high average Cash Conversion Cycle of 78.25, which may not be favorable. The company has higher borrowings (698.80) compared to reserves (613.40), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Entero Healthcare Solutions Ltd:
1. Net Profit Margin: 1.01%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 5.8% (Industry Average ROCE: 6.71%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 2.38% (Industry Average ROE: 4.98%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.61
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.64
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 84.8 (Industry average Stock P/E: 84.8)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.16
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Pharmaceuticals

INDUSTRY	ADDRESS	CONTACT
Plot No. I-35, Building - B, Industrial Area, Phase - I, Faridabad Haryana 121003	Mr.	Sujesh%20Vasudevan Chairman(NonExe.&Ind.Director)

Management
Name	Position Held
Mr. Prabhat Agrawal	Managing Director & CEO
Mr. Prem Sethi	Whole Time Director & COO
Mr. Rajesh Shashikant Dalal	Ind. Non-Executive Director
Ms. Sandhya Gadkari Sharma	Ind. Non-Executive Director
Mr. Arun Sadhanandham	Non Exe.Non Ind.Director
Mr. Vipul Indravadan Desai	Non Exe.Non Ind.Director
Ms. Sumona Chakraborty	Non Exe.Non Ind.Director
Mr. Kevin Rohitbhai Daftary	Additional Non Exe.Non Ind.Director

FAQ

What is the latest intrinsic value of Entero Healthcare Solutions Ltd?

The latest intrinsic value of Entero Healthcare Solutions Ltd as on 23 December 2024 is ₹1667.00, which is 19.67% higher than the current market price of ₹1,393.00. The stock has a market capitalization of 6,060 Cr. and recorded a high/low of 1,584/970 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,639 Cr and total liabilities of ₹2,653 Cr.

What is the Market Cap of Entero Healthcare Solutions Ltd?

The Market Cap of Entero Healthcare Solutions Ltd is 6,060 Cr..

What is the current Stock Price of Entero Healthcare Solutions Ltd as on 23 December 2024?

The current stock price of Entero Healthcare Solutions Ltd as on 23 December 2024 is 1,393.

What is the High / Low of Entero Healthcare Solutions Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Entero Healthcare Solutions Ltd stocks is 1,584/970.

What is the Stock P/E of Entero Healthcare Solutions Ltd?

The Stock P/E of Entero Healthcare Solutions Ltd is 84.8.

What is the Book Value of Entero Healthcare Solutions Ltd?

The Book Value of Entero Healthcare Solutions Ltd is 387.

What is the Dividend Yield of Entero Healthcare Solutions Ltd?

The Dividend Yield of Entero Healthcare Solutions Ltd is 0.00 %.

What is the ROCE of Entero Healthcare Solutions Ltd?

The ROCE of Entero Healthcare Solutions Ltd is 6.71 %.

What is the ROE of Entero Healthcare Solutions Ltd?

The ROE of Entero Healthcare Solutions Ltd is 4.98 %.

What is the Face Value of Entero Healthcare Solutions Ltd?

The Face Value of Entero Healthcare Solutions Ltd is 10.0.